Elise Yazbeck

Treatment and outcome of aquaporin-4 antibody–positive NMOSD

Renata Barbosa Paolilo, Yael Hacohen, Elise Yazbeck et al. · Neurology Neuroimmunology & Neuroinflammation · 2020 · 67 citations · Full text

Safety and efficacy of leriglitazone for preventing disease progression in men with adrenomyeloneuropathy (ADVANCE): a randomised, double-blind, multi-centre, placebo-controlled phase 2–3 trial

Wolfgang Köhler, Marc Engelen, Florian Eichler et al. · The Lancet Neurology · 2023 · 38 citations · Full text

Non-pharmacological Intervention, Disease Progression, Diabetic Neuropathy +6

Risk factors for academic difficulties in children with myelin oligodendrocyte glycoprotein antibody‐associated acute demyelinating syndromes

Kumaran Deiva, Álvaro Cobo‐Calvo, Hélène Maurey et al. · Developmental Medicine & Child Neurology · 2020 · 30 citations

Mild Encephalitis/Encephalopathy with reversible splenial lesion syndrome: An unusual presentation of anti-GFAP astrocytopathy

Valentin Oger, Chloé Bost, Lucie Salah et al. · European Journal of Paediatric Neurology · 2020 · 29 citations · Full text

Anti-gfap Astrocytopathy, Mild Encephalitis/encephalopathy, Unusual Presentation +8

ATP2B2 de novo variants as a cause of variable neurodevelopmental disorders that feature dystonia, ataxia, intellectual disability, behavioral symptoms, and seizures

Elena Poggio, Lucia Barazzuol, Andrea Salmaso et al. · Genetics in Medicine · 2023 · 19 citations · Full text

Neurodevelopmental Disorders, Variable Neurodevelopmental Disorders, Behavioral Symptoms +9